Search - tctmd.com

Displaying 361 - 380 of 539

Sort: Relevancy | Date

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

News Conference News ACC 2017

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Michael O'Riordan

March 10, 2017

News Daily News

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Shelley Wood

March 06, 2017

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

News Daily News

Same-Day Discharge and Transradial Access: ‘Millions’ of Dollars in Cost Savings on the Table

Yael L. Maxwell

February 20, 2017

News Conference News CRT 2017

Suspended Lead Curtain, Robotic PCI, Offer Significant Head Protection from Radiation During PCI

Michael O'Riordan

February 20, 2017

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

News Daily News

Minding the Gaps: Race and Sex Disparities in Rehospitalization Post-MI Might Be Due to Angina, Depression

Yael L. Maxwell

February 10, 2017

News Daily News

Coronary Calcium IDs Higher Heart Disease Risk Even in Younger Adults

Todd Neale

February 10, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

Contact-to-Device Delays and Higher Mortality Seen in Women vs Men Presenting With STEMI

L.A. McKeown

January 18, 2017

News Daily News

Smoking and Acute MI: The Younger the Patient, the Higher the Risk

L.A. McKeown

December 02, 2016

News Daily News

Beta-blocker Therapy Seems to Boost Post-PCI Outcomes in Patients With ACS

Todd Neale

November 22, 2016

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

News Conference News AHA 2016

Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI

Todd Neale

November 14, 2016

Advertisement

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Same-Day Discharge and Transradial Access: ‘Millions’ of Dollars in Cost Savings on the Table

Suspended Lead Curtain, Robotic PCI, Offer Significant Head Protection from Radiation During PCI

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Minding the Gaps: Race and Sex Disparities in Rehospitalization Post-MI Might Be Due to Angina, Depression

Coronary Calcium IDs Higher Heart Disease Risk Even in Younger Adults

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Contact-to-Device Delays and Higher Mortality Seen in Women vs Men Presenting With STEMI

Smoking and Acute MI: The Younger the Patient, the Higher the Risk

Beta-blocker Therapy Seems to Boost Post-PCI Outcomes in Patients With ACS

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content